Applied Therapeutics Ownership | Who Owns Applied Therapeutics?

Overview Forecast RevenueFinancials Chart

Applied Therapeutics Ownership Summary

Applied Therapeutics is owned by 27.72% institutional investors, 4.90% insiders, and 67.38% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 64.40% of APLT shares. T. Rowe Price Small-Cap Value is the top mutual fund, with 8.10% of its assets in Applied Therapeutics shares.

APLT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Applied Therapeutics	27.72%	4.90%	67.38%
Sector	Healthcare Stocks	279.42%	10.64%	-190.05%
Industry	Biotech Stocks	64.05%	10.69%	25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	9.30M	64.40%	$7.96M
Schonfeld strategic advisors	8.76M	60.70%	$7.50M
Vanguard group	5.55M	38.44%	$4.75M
T. rowe price investment management	5.42M	37.56%	$4.64M
Deutsche bank ag\	4.47M	30.95%	$3.84M
Simplify asset management	2.82M	19.52%	$2.41M
Alyeska investment group	2.71M	18.76%	$2.32M
Tang capital management	2.43M	16.82%	$2.08M
Geode capital management	2.08M	14.44%	$1.78M
State street	2.07M	14.32%	$1.77M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Propel bio management	11.29M	6.41%	$5.52M
Stempoint capital lp	2.21M	3.03%	$10.33M
Knoll capital management	7.80M	2.48%	$3.81M
Vestal point capital, lp	11.50M	0.40%	$5.62M
Vr adviser	5.57M	0.23%	$2.72M
Tang capital management	2.43M	0.14%	$2.08M
Artal group	1.01M	0.12%	$4.71M
Simplify asset management	2.82M	0.12%	$2.41M
Rock springs capital management lp	1.92M	0.06%	$1.64M
Schonfeld strategic advisors	8.76M	0.04%	$7.50M

Top Buyers

Holder	Shares	% Assets	Change
Schonfeld strategic advisors	8.76M	0.04%	8.42M
Blackrock	6.57M	0.00%	5.58M
T. rowe price investment management	5.42M	0.00%	5.21M
Blackrock funding, inc. /de	9.30M	0.00%	2.35M
Knoll capital management	7.80M	2.48%	2.00M

Top Sellers

Holder	Shares	% Assets	Change
Franklin resources	2.00M	0.00%	-4.80M
Vr adviser	5.57M	0.23%	-4.42M
Frazier life sciences management	-	-	-2.29M
Adage capital partners gp	1.96M	0.00%	-2.15M
Siren	-	-	-1.63M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	243.20K	-	243.20K	$208.23K
Ubs asset management americas	119.03K	-	119.03K	$101.89K
Private advisor group	40.30K	0.00%	40.30K	$34.51K
Cantor fitzgerald, l. p.	25.00K	0.00%	25.00K	$21.41K
China universal asset management	24.67K	0.00%	24.67K	$21.12K

Sold Out

Holder	Change
Ifp advisors	-1.00
National bank of canada /fi/	-4.00
Headlands	-23.00
Geowealth management	-27.00
Advisor group	-70.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	7	-94.62%	37,179,368	-67.70%	27	0.00%	2	-97.53%	2	-92.31%
Dec 31, 2024	127	-11.19%	109,297,179	-3.04%	757	0.12%	79	-8.14%	26	-18.75%
Sep 30, 2024	143	41.58%	112,721,880	9.20%	780	11.51%	85	37.10%	33	37.50%
Jun 30, 2024	101	1.00%	103,226,978	9.86%	82	1.47%	62	-7.46%	24	50.00%
Mar 31, 2024	100	12.36%	93,965,703	53.04%	74	1.41%	67	15.52%	16	45.45%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
T. Rowe Price Small-Cap Value	11.47M	8.10%	-13.42K
T. Rowe Price U.S. SC Value Eq Tr-D	6.65M	4.70%	3.00M
Simplify Propel Opportunities ETF	4.49M	3.17%	-
Vanguard US Total Market Shares ETF	3.15M	2.71%	-
T. Rowe Price U.S. SC Value Eq Tr-Z	3.65M	2.66%	1.76M
Vanguard Total Stock Mkt Idx Inv	3.10M	2.19%	-
SPDR® S&P Biotech ETF	1.74M	1.49%	24.74K
Janus Henderson Global Life Sciences D	1.62M	1.39%	1.30M
Janus Henderson Glb Life Scn I2 USD	1.29M	1.11%	1.29M
Franklin Biotechnology Discv A(acc)USD	1.26M	0.89%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 04, 2025	Perfetti Riccardo	Chief Medical Officer	Sell	$4.56K
Mar 04, 2025	Funtleyder Leslie D.	See Remarks	Sell	$6.38K
Mar 04, 2025	Chinoporos Constantine	See Remarks	Sell	$196.68
Feb 06, 2025	Funtleyder Leslie D.	See Remarks	Sell	$14.00K
Feb 06, 2025	Perfetti Riccardo	Chief Medical Officer	Sell	$52.51K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	6
2024 Q4	-	-
2024 Q3	-	5

APLT Ownership FAQ

Who Owns Applied Therapeutics?

Applied Therapeutics shareholders are primarily institutional investors at 27.72%, followed by 4.90% insiders and 67.38% retail investors. The average institutional ownership in Applied Therapeutics's industry, Biotech Stocks , is 64.05%, which Applied Therapeutics falls below.

Who owns the most shares of Applied Therapeutics?

Applied Therapeutics’s largest shareholders are Blackrock funding, inc. /de (9.3M shares, 64.40%), Schonfeld strategic advisors (8.76M shares, 60.70%), and Vanguard group (5.55M shares, 38.44%). Together, they hold 163.54% of Applied Therapeutics’s total shares outstanding.

Does Blackrock own Applied Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Applied Therapeutics.

Who is Applied Therapeutics’s biggest shareholder by percentage of total assets invested?

Propel bio management is Applied Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.41% of its assets in 11.29M Applied Therapeutics shares, valued at 5.52M$.

Who is the top mutual fund holder of Applied Therapeutics shares?

T. Rowe Price Small-Cap Value is the top mutual fund holder of Applied Therapeutics shares, with 8.10% of its total shares outstanding invested in 11.47M Applied Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools